Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Pereskia aculeata miller as a source of betalains: optimization of extraction conditions, colour stability, and antioxidant potential.

Created on 06 Jul 2026

Authors

Nayara Andrade de Oliveira, Caroline Dambroz, Bárbara Sayuri Bellete, Tatiana Cardoso E Bufalo, Joyce Dória

Published in

Natural product research. Pages 1-7. Jul 05, 2026. Epub Jul 05, 2026.

Abstract

This study reports, for the first time, the presence of betalains in the apical leaves of Pereskia aculeata Mill., a species traditionally recognised for its nutritional, technological and medicinal value. While betalains production in P. aculeata callus cultures is documented, this research identified these compounds in apical leaves, optimised extraction conditions, evaluated colour stability at varying pH levels, and analysed the extract's antioxidant potential. Response surface methodology (RSM) using a Box-Behnken design was applied to optimise the extraction conditions. The optimal parameters were a mass/solvent ratio of 0.01 g/mL, extraction temperature of 45 °C, and extraction time of 3.42 min. The optimised extract exhibited antioxidant activity and marked colour variation under alkaline conditions. HPLC-DAD analysis showed co-elution with the betanin standard at 7.4 min, and UV-Vis spectra exhibited absorption maximum at 536 nm. These findings establish P. aculeata apical leaves as a novel and promising natural source of betalains.

PMID:
42402177
Bibliographic data and abstract were imported from PubMed on 06 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement